Wu et al. reported that MALAT1 is an active promoter of NAFLD-associated fibrosis as it was found to upregulate post-TGF-β1 exposure and was associated with a reduced expression of SIRT1 in CCL4-treated mice and in LX-2 HSCs [237]. This evidence concerns the gene SIRT1 and metabolic dysfunction-associated steatotic liver disease.